ADVERTISEMENT

Original Article

Basic Fibroblast Growth Factor Treatment for Skin Ulcerations in Scleroderma
Yamanaka K-i, Inaba T, Nomura E, Hurwitz D, Jones DA, Hakamada A, Isoda K, Kupper TS, Mizutani H
Cutis. 2005;76:373-376.
We report the use of topical application of recombinant human basic fibroblast growth factor (rhbFGF) to successfully treat therapy-resistant, chronic leg ulcers in scleroderma. Endothelial cell FGF receptors are directly stimulated by bFGF; also, bFGF promotes the regeneration of capillary-rich granulation tissue. We conclude that topical bFGF may be a powerful new pharmacologic tool for treating severe skin ulcers.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Breaking News

More News

FEATURED JOB from MedOpportunities.com